Authors' reply to "Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint".

Tanaka R, Coleman MP, Matsuzaka M, Sugiyama H, Di Carlo V, Matsuda T, Allemani C.

DOI: 10.1093/jjco/hyag076
Published: 2026-09-01
Container: Jpn J Clin Oncol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jjco/hyag076,
  title = {Authors' reply to "Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint".},
  author = {Tanaka R and  Coleman MP and  Matsuzaka M and  Sugiyama H and  Di Carlo V and  Matsuda T and  Allemani C.},
  year = {2026},
  journal = {Jpn J Clin Oncol},
  doi = {10.1093/jjco/hyag076},
  url = {https://doi.org/10.1093/jjco/hyag076}
}

RIS

TY  - JOUR
TI  - Authors' reply to "Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint".
AU  - Tanaka R
AU  -  Coleman MP
AU  -  Matsuzaka M
AU  -  Sugiyama H
AU  -  Di Carlo V
AU  -  Matsuda T
AU  -  Allemani C.
PY  - 2026
JO  - Jpn J Clin Oncol
DO  - 10.1093/jjco/hyag076
UR  - https://doi.org/10.1093/jjco/hyag076
ER  -

APA

R, T., MP, C., M, M., H, S., V, D. C., T, M., & C., A. (2026). Authors' reply to "Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint".. Jpn J Clin Oncol. https://doi.org/10.1093/jjco/hyag076

Source records

europe-pmc · retrieved 2026-09-26T09:20:05.896Z